Interrogating a white matter degeneration-specific astrocyte reactivity state and its role in governing repair-associated microglia specification and function.

询问白质变性特异性星形胶质细胞反应状态及其在控制修复相关小胶质细胞规格和功能中的作用。

基本信息

  • 批准号:
    10660874
  • 负责人:
  • 金额:
    $ 68.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-01 至 2028-01-31
  • 项目状态:
    未结题

项目摘要

Project Summary Clearance of cellular debris from the degenerating central nervous system (CNS) white matter is inefficient. Debris accumulation, especially from myelin, precipitates maladaptive neuroinflammation which furthers disease progression and prevents repair. Chronic white matter degeneration that produces cellular debris and protracted innate immune inflammation is a hallmark of diverse disorders, including traumatic and ischemic CNS injury and Multiple Sclerosis (MS). The development of therapies aimed enhancing debris clearance to promote repair is thereby of broad translational relevance. Research aimed at uncovering central regulatory mechanisms underlying the inflammatory response that facilitates debris clearance after white matter insult is therefore prudent and necessary. The overarching objective of this research is to dissect molecular pathways of astrocyte- microglia interaction that govern pro-restorative CNS innate immune responses to white matter degeneration. The present research will investigate a newly identified mechanism of intercellular communication, through which a distinct subpopulation of white matter degeneration-reactive astrocytes regulate microglia specification and function required for the removal of inflammatory myelin debris and tissue repair. In Aim 1, we will use a transgenic, cell type-specific loss-of-function system, single-nucleus RNA-Sequencing (snRNA-Seq) and mouse models of acute and chronic white matter degeneration to assess the involvement of this unique astrocyte- mediated signaling pathway in regulating damage-responsive microglia specification required for myelin debris clearance and remyelination. In Aim 2, we will dissect the direct effects and receptor dependent mechanism of action for a novel astrocyte-derived molecular cue on microglia molecular profile, motility, and capacity for myelin debris phagocytosis using cultures of mouse primary and human iPSC-derived microglia. In Aim 3, we will determine cell-intrinsic regulatory pathways underlying molecularly and functionally distinct states of white matter astrocyte reactivity using cell-paired snRNA-Seq and single-nucleus Assay for Transposase-Accessible Chromatin using Sequencing (snATAC-Seq), over time, in a mouse model of chronic white matter degeneration. An integrative analysis pipeline will be used to generate gene regulatory programs of astrocyte reactivity, including dynamic changes in chromatin structure and context-specific combinations of transcriptional regulators (TR), which together govern genetic accessibility and distinct reactive changes in transcriptomic profile. Select TR of molecularly distinct states of white matter astrocyte reactivity will be functionally interrogated in vivo by loss-of-function studies. Together, this research will enhance the understanding of how astrocyte-microglia interactions shape CNS innate immune responses that enable white matter repair. These data may also inform new therapeutic avenues for harnessing restorative innate immune responses, involving astrocytes and microglia, to prevent or attenuate maladaptive white matter inflammation, as well as improve outcome and promote recovery after CNS injury and in disease.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joshua Evan Burda其他文献

Joshua Evan Burda的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joshua Evan Burda', 18)}}的其他基金

Astrocyte regulation of neural plasticity after CNS injury
星形胶质细胞对中枢神经系统损伤后神经可塑性的调节
  • 批准号:
    10004175
  • 财政年份:
    2018
  • 资助金额:
    $ 68.52万
  • 项目类别:
Astrocyte regulation of intraspinal plasticity and spontaneous recovery after SCI
星形胶质细胞对脊髓损伤后椎管内可塑性和自发恢复的调节
  • 批准号:
    9123306
  • 财政年份:
    2016
  • 资助金额:
    $ 68.52万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.52万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 68.52万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.52万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.52万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.52万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.52万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.52万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 68.52万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 68.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 68.52万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了